Metropolis Healthcare Limited - Laporan Laba Rugi (TTM)

Metropolis Healthcare Limited
IN ˙ NSEI
₹ 2,206.55 ↓ -29.00 (-1.30%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Metropolis Healthcare Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 8,613 9,132 9,980 11,816 11,959 12,142 12,283 11,814 11,792 11,716 11,482 11,454 11,536 11,593 12,077 12,440 12,853 13,169 13,312 14,039
Change (%) 6.03 9.28 18.40 1.21 1.53 1.17 -3.82 -0.19 -0.64 -1.99 -0.24 0.71 0.49 4.18 3.00 3.32 2.46 1.09 5.46
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 2,290 2,460 2,702 3,050 2,994 2,931 2,976 2,861 2,857 2,866 2,741 2,696 2,624 2,558 2,699 2,761 2,843 2,916 3,030 3,189
Change (%) 7.43 9.83 12.87 -1.83 -2.11 1.55 -3.85 -0.16 0.30 -4.37 -1.64 -2.65 -2.53 5.51 2.29 2.97 2.57 3.92 5.25
% of Revenue 26.59 26.94 27.07 25.81 25.03 24.14 24.23 24.22 24.23 24.46 23.87 23.53 22.75 22.06 22.35 22.19 22.12 22.14 22.76 22.71
Gross Operating Profit 6,323 6,672 7,278 8,766 8,965 9,211 9,307 8,953 8,935 8,850 8,742 8,759 8,912 9,035 9,378 9,679 10,010 10,254 10,282 10,850
Change (%) 5.52 9.08 20.45 2.27 2.74 1.04 -3.81 -0.20 -0.95 -1.22 0.20 1.75 1.38 3.80 3.21 3.42 2.43 0.28 5.52
% of Revenue 73.41 73.06 72.93 74.19 74.97 75.86 75.77 75.78 75.77 75.54 76.13 76.47 77.25 77.94 77.65 77.81 77.88 77.86 77.24 77.29
SG&A 2,545 2,590 2,746 2,865 2,899 2,995 3,649 3,688 3,785 3,806 3,730 3,758 3,840 3,889 4,138 4,204 4,291 4,411 4,798 5,004
Change (%) 1.78 6.02 4.32 1.18 3.30 21.84 1.08 2.63 0.55 -2.00 0.76 2.16 1.28 6.41 1.60 2.07 2.78 8.79 4.29
% of Revenue 29.55 28.37 27.52 24.25 24.24 24.66 29.70 31.22 32.10 32.49 32.48 32.81 33.28 33.55 34.26 33.80 33.39 33.49 36.04 35.64
R&D 67 64 54 54 60 71 69 76 78 77 66 63 75 77 136 138 141 144 102 132
Change (%) -4.62 -15.29 0.07 10.49 17.52 -2.38 10.72 1.49 -1.06 -14.44 -4.86 19.31 2.64 77.34 1.79 1.97 2.19 -29.17 29.51
% of Revenue 0.78 0.70 0.55 0.46 0.50 0.58 0.56 0.65 0.66 0.66 0.57 0.55 0.65 0.66 1.12 1.11 1.10 1.09 0.77 0.94
OpEx 6,853 7,146 7,556 8,524 8,714 9,069 9,467 9,415 9,570 9,604 9,445 9,469 9,600 9,732 10,126 10,377 10,685 10,957 11,356 12,026
Change (%) 4.29 5.74 12.81 2.22 4.07 4.39 -0.54 1.64 0.35 -1.65 0.26 1.38 1.38 4.04 2.48 2.97 2.55 3.64 5.91
% of Revenue 79.56 78.25 75.72 72.14 72.86 74.69 77.07 79.69 81.16 81.97 82.26 82.67 83.22 83.95 83.84 83.42 83.14 83.20 85.30 85.66
Operating Income 1,761 1,986 2,423 3,292 3,245 3,073 2,817 2,399 2,222 2,112 2,037 1,985 1,936 1,860 1,951 2,063 2,168 2,212 1,956 2,013
Change (%) 12.81 22.03 35.83 -1.41 -5.31 -8.35 -14.82 -7.40 -4.94 -3.54 -2.55 -2.46 -3.93 4.89 5.72 5.08 2.06 -11.56 2.88
% of Revenue 20.44 21.75 24.28 27.86 27.14 25.31 22.93 20.31 18.84 18.03 17.74 17.33 16.78 16.05 16.16 16.58 16.86 16.80 14.70 14.34
Interest Expense -81 -73 -78 -116 -131 -164 -197 -216 -255 -267 -268 -253 -239 -231 -225 -212 -203 -195 -186 -191
Change (%) -9.24 6.04 48.51 13.20 25.33 20.41 9.54 18.13 4.49 0.40 -5.78 -5.19 -3.35 -2.61 -5.89 -4.18 -3.81 -4.97 2.94
% of Revenue -0.94 -0.80 -0.78 -0.98 -1.09 -1.35 -1.61 -1.83 -2.17 -2.28 -2.33 -2.20 -2.08 -2.00 -1.87 -1.70 -1.58 -1.48 -1.40 -1.36
Net Income 1,207 1,372 1,831 2,551 2,531 2,355 2,142 1,727 1,548 1,495 1,429 1,383 1,334 1,248 1,278 1,370 1,480 1,522 1,450 1,521
Change (%) 13.66 33.41 39.32 -0.79 -6.93 -9.07 -19.37 -10.39 -3.39 -4.44 -3.22 -3.53 -6.48 2.45 7.16 8.08 2.84 -4.77 4.91
% of Revenue 14.02 15.03 18.35 21.59 21.16 19.40 17.44 14.62 13.12 12.76 12.44 12.07 11.56 10.76 10.58 11.01 11.52 11.56 10.89 10.83

Source: Capital IQ

Other Listings
IN:542650
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista